Skip to main content

Table 1 Patient characteristics. Data are presented as mean (standard deviation) or number of patients

From: Magnesium sulfate reduces the rocuronium dose needed for satisfactory double lumen tube placement conditions in patients with myasthenia gravis

 

Magnesium sulfate group (n = 23)

Normal saline group(n = 22)

P

Age (year)

34.4 (11.3)

30.3 (9.0)

0.185

Body weight

55.8 (8.0)

60.5 (11.0)

0.111

BMI (kg.m−2)

21.7 (2.0)

22.2 (3.0)

0.577

Sex (Male/Female)

4/19

7/15

0.260

MG history ≥6 years/< 6 years

6/17

8/14

0.457

Osserman stage(I/IIa/IIb)

6/11/6

8/6/8

0.364

Operating time (minutes)

110.1 (31.6)

117.7 (24.4)

0.370

Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us